A prospective open label trial of low dose ketamine for acute suicidal states in the emergency department [abstract]
Larkin GL, Beautris AL, Powsner SM, et al. A prospective open label trial of low dose ketamine for acute suicidal states in the emergency department [abstract]. Ann Emerg Med. 2010;56(3):S53.
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder
DiazGranados N, Ibrahim LA, Brutsche NE, et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry. 2010;71(12):1605-1611.
The effects of small-dose ketamine on propofol sedation: respiration, postoperative mood, perception, cognition, and pain
Mortero RF, Clark LD, Tolan MM, Metz RJ, Tsueda K, Sheppard RA. The effects of small-dose ketamine on propofol sedation: respiration, postoperative mood, perception, cognition, and pain. Anesth Analg. 2001;92(6):1465-1469.
(2001)Anesth Analg, vol.92, Issue.6, pp. 1465-1469
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Zarate CA Jr, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856-864.
Mount Sinai School of Medicine in collaboration with US Department of Defense. Ketamine as a Rapid Treatment for Post-Traumatic Stress Disorder (PTSD).
NCT00749203. September 5, 2008 Available from: Accessed February 2
Mount Sinai School of Medicine in collaboration with US Department of Defense. Ketamine as a Rapid Treatment for Post-Traumatic Stress Disorder (PTSD). ClinicalTrials.gov Identifier: NCT00749203. September 5, 2008. Available from: http://clinicaltrials.gov/show/NCT00749203. Accessed February 2, 2011.